city New York covid-19 Ventilators patient city New York

Antibody cocktail treatments show some benefit in 2 COVID studies

Reading now: 625
www.cidrap.umn.edu

Two studies published yesterday in the New England Journal of Medicine discuss outcomes in COVID-19 patients given monoclonal antibody treatments, one showing that tocilizumab lowered the odds of needing mechanical ventilation and death but did not improve survival, and the other finding that REGN-COV2 lowered viral load—particularly in patients whose immune response hadn't yet been triggered or had a high viral load at baseline.Most benefit in moderate to severe illness The first study, a six-country phase 3 clinical trial led by a researcher at Mount Sinai Hospital in New York City, involved randomly assigning 377 adult COVID-19 patients not on mechanical ventilation to receive either two doses of the anti-interleukin-6 receptor antibody

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA